Renal Business Today

End-Stage Renal Disease (ESRD)

KAI Starts Phase 2 Study of CKD-MBD Drug

SOUTH SAN FRANCISCO, Calif.— KAI Pharmaceuticals Inc. has started patient enrollment in the second phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients ...More
January 6, 2012
Posted in News
Study Finds Changes in Incidence of ESRD from Lupus Nephritis

BOSTON—New research documenting changes in the incidence and outcomes of end-stage renal disease (ESRD) in the U.S. between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans. A second related ...More
March 29, 2011
Posted in News, Clinical & Pharma
Groups Develop ESRD Hospice, Palliative Care Education

MIDLOTHIAN, Va.—The Kidney End-of-Life Coalition and the American Nephrology Nurses’ Association (ANNA) have developed an educational module for the coordination of hospice and palliative care in end-stage renal disease (ESRD). ...More
February 17, 2011
Posted in News, Practice Management
Number of Canadians with ESRD Tripled Since 1990

TORONTO—The number of Canadian kidney failure patients has tripled in the last 20 years, but rates have been stabilizing, according to a report from the Canadian Institute for Health Information (CIHI). ...More
January 21, 2011
Posted in News, Clinical & Pharma, Practice Management
Rapid Kidney-Function Decline Leads to Greater Risk of Premature Death

Rapid kidney function decline leads to a higher risk of premature death compared with patients whose kidney function decline is mild, according to a study published online Oct. 14 in the Journal of the American Society of Nephrology (JASN). ...More
October 15, 2010
Posted in News, Clinical & Pharma
Healthy Blood Pressure May Help Some African Americans with Kidney Disease

Keeping blood pressure at a low level in African Americans with kidney disease may slow the progression of the condition in patients with proteinuria, UT Southwestern Medical Center researchers found in a national study published in The New England Journal of Medicine. ...More
October 14, 2010
Posted in News, Clinical & Pharma
Black, Hispanic Kidney Donors More Likely to Develop CKD

BOSTON—Black and Hispanic kidney donors are significantly more likely than white donors to develop hypertension, diabetes and chronic kidney disease, according to new Saint Louis University research published in the Aug. 19 issue of the New England Journal of Medicine. ...More
August 20, 2010
Posted in News, Clinical & Pharma
Heart Drug May be Unsafe for Some Kidney Patients

For patients with kidney disease on dialysis, the widely used heart medication digoxin may lead to an increased risk of premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). ...More
June 25, 2010
Posted in News, Clinical & Pharma
ESRD Market Basket and How it Affects You

AS WE WAIT for the issuance of the final rule on the new end-stage renal disease bundle I am busy preparing ESRD facility cost reports for those providers with a fiscal year that ends on Dec. 31, 2009. ...More
June 16, 2010
Posted in Articles, Business, Government & Regulation, Practice Management
Genetic Factors Can Help Predict Risk for Kidney Disease

HAIFA, Israel—Israeli and American researchers have identified new genetic data that could be used in the future to predict who will develop end-stage renal disease, according to a study in the Feb. 9th issue of Human Molecular Genetics. ...More
February 24, 2010
Posted in News, Clinical & Pharma, Government & Regulation

featured links

HOT TOPICS

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

End-Stage Renal Disease (ESRD)

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail